{"id":"W2085481779","doi":"10.1310/hct1105-260","title":"A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Raltegravir; Abacavir; Medicine; Lamivudine; Adverse effect; Viral load; Internal medicine; Discontinuation; Gastroenterology; Human immunodeficiency virus (HIV); Virology; Chronic hepatitis; Antiretroviral therapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002806151,0.001262765,0.001984728,0.0002237306,0.0002693836,0.0006817481,0.0006314312,0.0008410513,0.003658925],"category_scores_gemma":[0.00184219,0.0005161611,0.001917338,0.0001936091,0.0008520141,0.0008057312,0.0003984352,0.002064219,0.0007178844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003796002,"about_ca_system_score_gemma":0.0009486253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006258042,"about_ca_topic_score_gemma":0.001044511,"domain_scores_codex":[0.9990056,0.0006769256,0.00005140017,0.00007819194,0.0000596328,0.0001282211],"domain_scores_gemma":[0.9977953,0.0005868124,0.0003753918,0.0002213954,0.0001399112,0.0008811938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9373628,0.01645251,0.007231602,0.0002617518,0.001377932,0.0002011923,0.0002115625,0.0007251567,0.009383985,0.0001129024,0.001425096,0.02525352],"study_design_scores_gemma":[0.5367233,0.4444253,0.01439355,0.00002827197,0.0006339425,0.0002963133,0.00007108827,0.0007540789,0.001329568,0.0001083542,0.001206389,0.00002987548],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973501,0.0008515724,0.0001632757,0.000213658,0.00005578041,0.0003534896,0.0003530605,0.00004222513,0.0006168308],"genre_scores_gemma":[0.9958704,0.0005273632,0.0007633734,0.0003519279,0.0002137071,0.0004594284,0.000894565,0.00001676535,0.0009024845],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003658925,"threshold_uncertainty_score":0.01484054,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.152403599521089,"score_gpt":0.4151683571378847,"score_spread":0.2627647576167957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}